Page last updated: 2024-10-30

kynurenic acid and Toxoplasmosis

kynurenic acid has been researched along with Toxoplasmosis in 1 studies

Kynurenic Acid: A broad-spectrum excitatory amino acid antagonist used as a research tool.
kynurenic acid : A quinolinemonocarboxylic acid that is quinoline-2-carboxylic acid substituted by a hydroxy group at C-4.

Toxoplasmosis: The acquired form of infection by Toxoplasma gondii in animals and man.

Research Excerpts

ExcerptRelevanceReference
" Notably, the anti-parasitic drugs pyrimethamine and sulfadiazine, a standard treatment of toxoplasmosis, significantly reduced 3-HK and KYNA levels in the brain of infected mice when applied between 28 and 56 days post-infection."3.80Evaluation of kynurenine pathway metabolism in Toxoplasma gondii-infected mice: implications for schizophrenia. ( Fang, Q; Harris, TH; Horning, KJ; Hunter, CA; Notarangelo, FM; Schwarcz, R; Thomas, MA; Wilson, EH, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Notarangelo, FM1
Wilson, EH1
Horning, KJ1
Thomas, MA1
Harris, TH1
Fang, Q1
Hunter, CA1
Schwarcz, R1

Other Studies

1 other study available for kynurenic acid and Toxoplasmosis

ArticleYear
Evaluation of kynurenine pathway metabolism in Toxoplasma gondii-infected mice: implications for schizophrenia.
    Schizophrenia research, 2014, Volume: 152, Issue:1

    Topics: Animals; Anti-Infective Agents; Brain; Disease Models, Animal; Drug Combinations; Female; Kynurenic

2014